Gilead Sciences logo
Home
Facebook
Twitter
Linkedin
Summary:
COMPANY:​
Gilead Sciences
INDUSTRIES:​
Biopharma, Biotechnology, Commercial, Health Care, Manufacturing, Pharmaceutical
HEADQUARTERS:​
Foster City, California, United States
ABOUT:
Gilead Sciences is a biopharmaceutical company that discovers, develops, manufactures and commercializes therapies for critical diseases.
STOCK SYMBOL:
GILD: BIT – Italian Stock Exchange
IPO STATUS:
Public
Gilead Sciences is a research-based biopharmaceutical company that discovers, develops, and commercializes innovative medicines in areas of unmet need. With each new discovery and experimental drug candidate, they seek to improve the care of patients suffering from life-threatening diseases. Gilead’s primary areas of focus include HIV/AIDS, liver disease, and serious cardiovascular and respiratory conditions. Gilead Sciences was founded in 1987 and headquartered in Foster City, California.
POWERED BY CRUNCHBASE
Financials:
FUNDING (USD):​
STATUS:
For Profit
INVESTORS:​
TOP 5 INVESTORS:​
FOUNDERS:​
Michael L. Riordan
LAST LEADERSHIP HIRE:
EMPLOYEES:
10001+
ACQUISITIONS​:

YouTube

Gilead Sciences

The way we see it, the impossible is not impossible. It’s simply what hasn’t been achieved yet. For more than 30 years, we’ve pursued it, chased it down, tackled it for answers and surrounded it for a way in. We have worked tirelessly to bring forward medicines for life-threatening diseases.

Read more: http://bit.ly/2vbkoI7

Gilead Sciences
Gilead’s Research Scholars Program supports innovative research from emerging investigators around the world to advance scientific knowledge in areas of unmet medical needs and improve the lives of patients everywhere. From the moment she set foot in Mwanza, Tanzania, Jennifer Downs has been committed to uplifting women’s health in the community. Her work led her to discover a link between a common local parasite and HIV infection rates in women. With support from Gilead’s Research Scholars Program, Jennifer is exploring the roots of the connection — and transforming patient care and women’s health along the way. Visit www.Gilead.com/RSP to learn more about the Research Scholars Program.
The Gilead Research Scholars Program: Transforming Patient Care
YouTube Video UCNSt7PtsfNGbezR9hmvRI1w_kye54XJcrxk
Gilead’s Research Scholars Program supports innovative research from emerging investigators around the world to advance scientific knowledge in areas of unmet medical needs and improve the lives of patients everywhere. As an early-career research scientist, Stephen Chan faced doubts about his ability to continue his work without adequate funding. Encouraged by his mentor, he applied to Gilead’s Research Scholars Program, which enabled him to pursue his research of pulmonary hypertension — while also serving as a mentor to other junior scientists. Modeling his own mentorship style on what he experienced, Stephen is just one of the many examples of how the Research Scholar Program works to advance science, together. Visit www.Gilead.com/RSP to learn more about the Research Scholars Program.
The Gilead Research Scholars Program: Advancing Science Together
YouTube Video UCNSt7PtsfNGbezR9hmvRI1w_qEBRLNCLIQk
Gilead’s Research Scholars Program supports innovative research from emerging investigators around the world to advance scientific knowledge in areas of unmet medical needs and improve the lives of patients everywhere. Inspired by the example his father set for him at a young age, Takahiro Kodama had long aspired discover something new and notable for humanity. As he began the early stages of his career, he set out to explore how a genetic mutation impacts the development of advanced liver cancer. Now, his research is helping progress our understanding of the disease so we can better treat patients — and one day perhaps even prevent or cure it. Visit www.Gilead.com/RSP to learn more about the Research Scholars Program.
The Gilead Research Scholars Program: Discovering New Possibilities
YouTube Video UCNSt7PtsfNGbezR9hmvRI1w_76kRN4b1b38
Gilead HCV BCG Report
YouTube Video UCNSt7PtsfNGbezR9hmvRI1w_6_rNQ-DbJS0
Sir Elton John and David Furnish announced the first grantees of the RADIAN Model Cities program and Unmet Need fund. To address the challenges in Eastern Europe and Central Asia (EECA) and ensure no one is left behind in the global effort to end the HIV/AIDS epidemic, the Elton John AIDS Foundation and Gilead Sciences have partnered together in a ground-breaking initiative called RADIAN. RADIAN aims to meaningfully address new HIV infections and deaths from AIDS-related illnesses in EECA through focused action, investment and resourcing to improve the quality of prevention and care for people at risk of or living with HIV in the region. Learn more: www.radianhiv.org.
RADIAN IAS 2020 Elton John & David Furnish Announcement video
YouTube Video UCNSt7PtsfNGbezR9hmvRI1w_8UH4Z8SCRQ8
Load More... Subscribe

Twitter:

Gilead Sciences
Gilead Sciences

This year, as we celebrate the Thanksgiving holiday, we want to share our gratitude for the frontline healthcare wo… https://t.co/KiPkATCb7o

Gilead Sciences
Gilead Sciences

This International #TDOR, we honor the victims of transphobic violence. We stand in solidarity with transgender com… https://t.co/qKKEEtfWgT

Gilead Sciences
Gilead Sciences

Gilead’s FOCUS program is a public health initiative focused on #HIV, #HCV and #HBV screening and linkage to care.… https://t.co/xUyGssAN4f

Gilead Sciences
Gilead Sciences

We released the following statement today related to the WHO COVID-19 treatment guidelines: https://t.co/vb8TG4CxYL.

Gilead Sciences
Gilead Sciences

Continued scientific innovation in HIV is essential to expanding HIV treatment strategies. Today, we announced new… https://t.co/uD3v11lax4

Gilead Sciences
Gilead Sciences

After learning of her own family’s history with #HBV and the devastation it can cause, Tram Tran, our Vice Presiden…

Tokyo Office:

Gran Tokyo South Tower, 16th Floor
1-9-2 Marunouchi, Chiyoda-ku
Tokyo, 100-6616

Tagged